BBIO

BridgeBio Pharma Inc

Jun 02 • 04:00PM ET

63.88

-1.48 -2.26 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ASND BMRN MDGL ALNY IONS KRYS EXEL RARE ARWR VRTX

| Held by: VTI VB IWM VBK VXF XBI IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.75	Insider Own	13.69%	Shs Outstand	195.71M	Perf Week	-5.68%
Market Cap	12.51B	Forward P/E	103.41	EPS next Y	0.62	Insider Trans	-2.60%	Shs Float	169.05M	Perf Month	-6.83%
Enterprise Value	14.97B	PEG	-	EPS next Q	-0.59	Inst Own	91.02%	Short Float	14.29%	Perf Quarter	-1.01%
Income	-721.55M	P/S	21.57	EPS this Y	42.04%	Inst Trans	5.02%	Short Ratio	9.65	Perf Half Y	-11.29%
Sales	579.96M	P/B	-	EPS next Y	128.20%	ROA	-64.06%	Short Interest	24.16M	Perf YTD	-16.49%
Book/sh	-11.64	P/C	13.30	EPS next 5Y	-	ROE	-	52W High	84.94 -24.79%	Perf Year	80.15%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	-5.07% 0.09%	ROIC	-135.35%	52W Low	34.13 87.17%	Perf 3Y	347.97%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.30% 127.44%	Gross Margin	94.69%	Volatility	3.90% 4.25%	Perf 5Y	7.52%
Dividend TTM	-	EV/Sales	25.80	EPS Y/Y TTM	-6.09%	Oper. Margin	-86.94%	ATR (14)	3.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	355.17%	Profit Margin	-124.41%	RSI (14)	38.84	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	4.35%	SMA20	-4.93%	Beta	0.98	Target Price	104.67
Payout	-	Debt/Eq	-	Sales Q/Q	66.78%	SMA50	-9.76%	Rel Volume	1.87	Prev Close	65.36
Employees	839	LT Debt/Eq	-	Earnings	May 07 AMC	SMA200	-3.95%	Avg Volume	2.51M	Price	63.88
IPO	Jun 27, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.75% 9.24%	Trades		Volume	4,696,990	Change	-2.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)